Rugo, H., Kaufman, P., Tan-Chiu, E., et al. (2008) Survival of Patients with HER-2(+)Metastatic Breast Cancer and Use of Trastuzumab Following Progression: Analysis of registHER. The 31st San Antonio Breast Cancer Symposium Proceedings, San Antonio, 10-14 December 2008.

HER-2阳性乳腺癌靶向治疗的心脏毒性综述
Cardiotoxicity of Targeted Therapy for HER-2 Positive Breast Cancer

石明强, 赵久达   

临床医学进展Vol.14 No.2, 全文下载: PDF HTML XML DOI:10.12677/ACM.2024.142614, February 29 2024

曲妥珠单抗、帕妥珠单抗联合多西他赛对晚期三阳性乳腺癌一线治疗的临床疗效
Clinical Efficacy of Trastuzumab, Pertuzumab and Docetaxel as First-Line Treatment for Metastatic Triple-Positive Breast Cancer

曹 宇, 孙 萍   

临床医学进展Vol.12 No.8, 全文下载: PDF HTML XML DOI:10.12677/ACM.2022.1281125, August 23 2022

曲妥珠单抗所致乳腺癌患者心脏毒性的中西医结合治疗进展
Research Progress of the Treatment of Combined Traditional Chinese and Western Medicine on Cardiotoxicity of Breast Cancer Patients Caused by Trastuzumab

项莲莲, 郝 炜   

中医学Vol.10 No.4, 全文下载: PDF HTML XML DOI:10.12677/TCM.2021.104069, July 8 2021

卡培他滨单药或联合方案治疗转移性乳腺癌临床疗效观察
Clinical Curative Effect Observation of the Treatment of Metastatic Breast Cancer (MBC) with Capecitabine Medicine or Combination Chemotherapy

李 杰, 李凤虎, 常建英, 李杰慧, 袁 佳, 刘诗苑, 冉 立    科研立项经费支持

临床医学进展Vol.4 No.4, 全文下载: PDF HTML DOI:10.12677/ACM.2014.44016, December 31 2014

优替德隆治疗晚期乳腺癌的临床疗效观察
Clinical Efficacy of Utidelone in the Treatment of Advanced Breast Cancer

赵婷婷, 赵 兵   

临床医学进展Vol.13 No.7, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.1371499, July 7 2023

CDK4/6抑制剂在HR+/HER-2−乳腺癌中耐药机制及生物标志物研究进展
Research Progress on Resistance Mechanism and Biomarker of CDK4/6 Inhibitor in HR+/HER-2− Breast Cancer

袁晓莉, 王振波   

临床医学进展Vol.11 No.12, 全文下载: PDF HTML XML DOI:10.12677/ACM.2021.1112851, December 16 2021